Does glycosylated haemoglobin (HbA1c) feedback from a Chronic Disease Management Register to treating General Practitioners have an impact on the management of diabetes and increase the proportion of patients with poorly controlled diabetes who achieve good control?

In diabetics with recent glycosylated haemoglobin (HbA1c) > 7 who are on a chronic disease patient register, does a reminder to their GPs about their HbA1c level, compared to usual care, impact upon the management of their diabetes and lead to an improvement in HbA1c levels?

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12612001276842

Enrollment

300

Registered

2012-12-10

Start date

2012-12-10

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To assess whether providing General Practitioners with reminders about their patients’ HbA1c results from a Chronic Disease Management Register leads to better diabetes control. This will be determined via GP Practice Visits and HbA1c levels.

Interventions

Letter from register to patient's GP reminding them of the patient's elevated HbA1c level. This letter will be sent to all GPs of patients in the intervention group once, at the same point in time. This point in time will be at the beginning of the study when all patients have been enrolled in the study.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Adults patients on the Chronic Disease Management Register who have a recent Hba1c level >7.

Exclusion criteria

Pregnant women. People unable to provide consent themselves.

Outcome results